Molecular weight (DA)
22kD
Immunogen
Synthesized peptide derived from human protein . at AA range: 61-110
Specificity
REEP1 Polyclonal Antibody detects endogenous levels of protein.
Formulation
Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
Dilution rate
WB 1:500-2000 ELISA 1:5000-20000
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
This gene encodes a mitochondrial protein that functions to enhance the cell surface expression of odorant receptors. Mutations in this gene cause spastic paraplegia autosomal dominant type 31, a neurodegenerative disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009],
Function
disease:Defects in REEP1 are the cause of spastic paraplegia autosomal dominant type 31 (SPG31) [MIM:610250]. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.,function:May enhance the cell surface expression of odorant receptors.,similarity:Belongs to the DP1 family.,subunit:Interacts with odorant receptor proteins.,
Protein name
Receptor expression-enhancing protein 1
Human protein sequence Database
Q9H902
Mouse protein sequence database
Q8BGH4
Rat protein sequence database
Cellular localization
Membrane . Mitochondrion membrane ; Multi-pass membrane protein . Endoplasmic reticulum . Localizes to endoplasmic reticulum tubular network. .
Tissue expression
Expressed in circumvallate papillae and testis.
Contract Us
Follow Us
Location： 
Specification
成功添加到购物车